GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
EBITDA Margin
9.05%
Quarterly · Period ending:
GSK EBITDA Margin
Latest reported9.05%period ending
Latest reported9.05%period ending
GSK Quarterly EBITDA Margin (100.00% → 9.05%)
Quarterly ebitda margin
High-resolution chart · PNG
GSK ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 9.0475% | |
| 36.3613% | |
| 22.1244% | |
| 39.3237% | |
| 40.4458% | |
| 41.1522% | |
| 13.7859% | |
| 14.6156% | |
| 29.2745% | |
| 28.1135% | |
| 14.3691% | |
| 31.3244% | |
| 36.5561% | |
| 39.5627% | |
| 25.0802% | |
| 27.6919% | |
| 29.1095% | |
| 37.7886% | |
| 12.5684% | |
| 34.6461% | |
| 30.901% | |
| 28.0399% | |
| 42.3962% | |
| 29.0308% | |
| 40.1889% | |
| 24.8405% | |
| 27.1173% | |
| 28.8652% | |
| 29.1587% | |
| 35.2695% | |
| 27.3637% | |
| 30.0791% | |
| 13.7209% | |
| 24.19% | |
| 5.5505% | |
| 33.0103% | |
| 15.041% | |
| 28.0336% | |
| 16.0954% | |
| 21.7979% | |
| 4.0723% | |
| 20.8541% | |
| 0.7159% | |
| 20.7932% | |
| 18.1895% | |
| 186.7841% | |
| 13.7569% | |
| 19.6245% | |
| 27.6569% | |
| 29.5386% | |
| 32.9134% | |
| 35.6989% | |
| 30.689% | |
| 33.5806% | |
| 37.9153% | |
| 29.9065% | |
| 30.4395% | |
| 34.5181% | |
| 30.8971% | |
| 38.1334% | |
| 33.75% | |
| 42.3235% | |
| -0.7086% | |
| 37.6046% | |
| 7.8861% | |
| 35.3677% | |
| 34.3094% | |
| 38.3693% | |
| 35.4824% | |
| 36.5194% | |
| 27.1346% | |
| 36.8242% | |
| 39.8025% | |
| 41.3999% | |
| 34.1648% | |
| 8.1779% | |
| 39.9542% | |
| 44.9392% | |
| 25.5603% | |
| 42.6445% | |
| 38.9458% | |
| 41.3892% | |
| -82.2321% | |
| 38.7315% | |
| 37.7309% | |
| 37.8674% | |
| 17.6112% | |
| 36.8837% | |
| 40.0121% | |
| 37.4871% | |
| 22.4003% | |
| 37.9985% | |
| 39.5567% | |
| 35.2962% | |
| 28.5815% | |
| 27.5354% | |
| 33.6288% | |
| 33.5225% | |
| 55.1317% | |
| 18.8226% |